| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848585 | American Journal of Kidney Diseases | 2013 | 14 Pages |
Abstract
MMF is as effective as cyclophosphamide in achieving remission in lupus nephritis, but is safer, with a lower risk of ovarian failure. MMF is more effective than azathioprine in maintenance therapy for preventing relapse, with no difference in clinically important side effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Lorna K. MBChB, PhD, Philip MBChB, Jonathan C. MBBS, PhD, Matthew A. MBBS, Robert S. MBBS, Giovanni F.M. MD, PhD, Angela C. MBChB, PhD,